Serum amyloid A as a biomarker in differentiating attacks of familial Mediterranean fever from acute febrile infections

[1]  H. Ozdogan,et al.  Familial Mediterranean Fever. , 2019, Presse medicale.

[2]  R. Papa,et al.  Secondary, AA, Amyloidosis. , 2018, Rheumatic diseases clinics of North America.

[3]  S. Masters,et al.  An Update on Autoinflammatory Diseases: Inflammasomopathies , 2018, Current Rheumatology Reports.

[4]  S. Özen,et al.  Familial Mediterranean Fever: Recent Developments in Pathogenesis and New Recommendations for Management , 2017, Front. Immunol..

[5]  A. Okoh,et al.  Lack of the Association of the PTPN22 C1858T Gene Polymorphism With Susceptibility to Familial Mediterranean Fever. , 2016, Archives of rheumatology.

[6]  A. Elhan,et al.  Late-onset disease is associated with a mild phenotype in children with familial Mediterranean fever , 2016, Clinical Rheumatology.

[7]  S. Ozen,et al.  What is the best acute phase reactant for familial Mediterranean fever follow-up and its role in the prediction of complications? A systematic review , 2016, Rheumatology International.

[8]  M. Fändrich,et al.  AA Amyloidosis : Pathogenesis and Targeted Therapy Gunilla , 2014 .

[9]  P. Hawkins,et al.  AA amyloidosis complicating the hereditary periodic fever syndromes. , 2013, Arthritis and rheumatism.

[10]  N. Akar,et al.  The value of procalcitonin measurements in children with familial Mediterranean fever , 2012, Rheumatology International.

[11]  I. Ben-Zvi,et al.  Chronic inflammation in FMF: markers, risk factors, outcomes and therapy , 2011, Nature Reviews Rheumatology.

[12]  A. Elhan,et al.  A new set of criteria for the diagnosis of familial Mediterranean fever in childhood. , 2009, Rheumatology.

[13]  A. Elhan,et al.  The value of the levels of acute phase reactants for the prediction of familial Mediterranean fever associated amyloidosis: a case control study , 2007, Rheumatology International.

[14]  D. Booth,et al.  Clinical and subclinical inflammation in patients with familial Mediterranean fever and in heterozygous carriers of MEFV mutations. , 2006, Rheumatology.

[15]  A. Larsson,et al.  Correlations between serum amyloid A protein and C‐reactive protein in infectious diseases , 2003, Scandinavian journal of clinical and laboratory investigation.

[16]  H. Yazici,et al.  Acute phase response in familial Mediterranean fever , 2002, Annals of the rheumatic diseases.

[17]  D. Zemer,et al.  Criteria for the diagnosis of familial Mediterranean fever. , 1997, Arthritis and rheumatism.

[18]  E. Sohar,et al.  Familial Mediterranean fever. , 1955, Klinische Padiatrie.